Human Longevity Inc.
Human Longevity is a San Diego-based venture launched by Craig Venter and Peter Diamandis in 2013. Its goal is to build the world's most comprehensive database on human genotypes and phenotypes, and then subject it to machine learning so that it can help develop new ways to fight diseases associated with aging. The company received US$80 million in investments in its Series A offering in summer 2014 and announced a further $220 million Series B investment offering in April 2016. It has made deals with drug companies Celgene and AstraZeneca to collaborate in its research.
Wikipage disambiguates
Wikipage redirect
primaryTopic
Human Longevity Inc.
Human Longevity is a San Diego-based venture launched by Craig Venter and Peter Diamandis in 2013. Its goal is to build the world's most comprehensive database on human genotypes and phenotypes, and then subject it to machine learning so that it can help develop new ways to fight diseases associated with aging. The company received US$80 million in investments in its Series A offering in summer 2014 and announced a further $220 million Series B investment offering in April 2016. It has made deals with drug companies Celgene and AstraZeneca to collaborate in its research.
has abstract
Human Longevity is a San Diego ...... rs for diseases later in life.
@en
country
Link from a Wikipage to an external page
Wikipage page ID
47,190,810
Wikipage revision ID
734,907,341
subject
hypernym
comment
Human Longevity is a San Diego ...... o collaborate in its research.
@en
label
Human Longevity Inc.
@en